Nonetheless, in individuals living with T2D, the insulin secretory response to GIP is impaired in only the late, but not the early phase of insulin secretion, suggesting that a GIPR defect unlikely accounts for the perturbed insulinotropic action of GIP in these subjects [151,160,182]. The gene discussed is INS; the disease is type 2 diabetes mellitus.